Trial document




drksid header

  DRKS00010092

Trial Description

start of 1:1-Block title

Title

Change in prescribing patterns in oral anticoagulation in general practices since the introduction of the New Oral Anticoagulants

end of 1:1-Block title
start of 1:1-Block acronym

Trial Acronym

[---]*

end of 1:1-Block acronym
start of 1:1-Block url

URL of the Trial

[---]*

end of 1:1-Block url
start of 1:1-Block public summary

Brief Summary in Lay Language

The study investigates the prescribing behavior of GPs regarding oral anticoagulants since the introduction of New Oral Anticoagulants (NOAC). It should retrospectively examine which anticoagulations the GPs favorited and how often a treatment were changed in one patient.

end of 1:1-Block public summary
start of 1:1-Block scientific synopsis

Brief Summary in Scientific Language

An oral anticoagulation (OAC) is performed in patients with an increased risk of thromboembolism in atrial fibrillation and after DVT and / or pulmonary embolism. Since 2012 in addition to Vitamin K antagonists (VKA), the new oral anticoagulants (NOAC) are available for all indications mentioned. Both agents can be used by primary care physicians, according to the current guidelines for the above indications. However, the professional societies prefer increasingly NOAC. The own professional society (DEGAM) recommends the use of NOAC only if reasons against the use of VKA are present in the patient. In a survey in 2012, the OAC was done at 88% with a VKA at German family practices. So far, it has not been studied how the prescription behavior of GPs has changed since the introduction of NOAC. By examining a future development could be estimated.

end of 1:1-Block scientific synopsis
start of 1:1-Block organizational data

Organizational Data

  •   DRKS00010092
  •   2016/04/19
  •   [---]*
  •   yes
  •   Approved
  •   018/16, Ethik-Kommission der Medizinischen Fakultät der Rheinischen Friedrich-Wilhelms-Universität Bonn
end of 1:1-Block organizational data
start of 1:n-Block secondary IDs

Secondary IDs

  • [---]*
end of 1:n-Block secondary IDs
start of 1:N-Block indications

Health Condition or Problem studied

  •   I48.0 -  [generalization I48: Atrial fibrillation and flutter]
end of 1:N-Block indications
start of 1:N-Block interventions

Interventions/Observational Groups

  •   From the medical records in addition to the biographical data information is extracted to medical history, long-term medication and change of anticoagulation.
end of 1:N-Block interventions
start of 1:1-Block design

Characteristics

  •   Non-interventional
  •   Observational study
  •   Single arm study
  •   Open (masking not used)
  •   [---]*
  •   Uncontrolled/Single arm
  •   Prevention
  •   Single (group)
  •   N/A
  •   N/A
end of 1:1-Block design
start of 1:1-Block primary endpoint

Primary Outcome

Prescription of oral anticoagulation

end of 1:1-Block primary endpoint
start of 1:1-Block secondary endpoint

Secondary Outcome

Indications for OAK, change of anticoagulation within one year, age, comorbidities, complications

end of 1:1-Block secondary endpoint
start of 1:n-Block recruitment countries

Countries of Recruitment

  •   Germany
end of 1:n-Block recruitment countries
start of 1:n-Block recruitment locations

Locations of Recruitment

  • Doctor's Practice 
end of 1:n-Block recruitment locations
start of 1:1-Block recruitment

Recruitment

  •   Planned
  •   2016/05/01
  •   300
  •   Monocenter trial
  •   National
end of 1:1-Block recruitment
start of 1:1-Block inclusion criteria

Inclusion Criteria

  •   Both, male and female
  •   no minimum age
  •   no maximum age
end of 1:1-Block inclusion criteria
start of 1:1-Block inclusion criteria add

Additional Inclusion Criteria

Taking an oral anticoagulation

end of 1:1-Block inclusion criteria add
start of 1:1-Block exclusion criteria

Exclusion Criteria

Missing taking oral anticoagulation

end of 1:1-Block exclusion criteria
start of 1:n-Block addresses

Addresses

  • start of 1:1-Block address primary-sponsor
    • Institut für Hausarztmedizin der Universität Bonn
    • Mr.  Prof. Dr.  Klaus  Weckbecker 
    • Sigmund-Freud-Str. 25
    • 53127  Bonn
    • Germany
    end of 1:1-Block address primary-sponsor
    start of 1:1-Block address contact primary-sponsor
    end of 1:1-Block address contact primary-sponsor
  • start of 1:1-Block address scientific-contact
    • Institut für Hausarztmedizin der Medizinischen Fakultät der Universität Bonn
    • Mr.  Dr.  Markus  Bleckwenn 
    • Sigmund - Freud - Straße 25
    • 53127  Bonn
    • Germany
    end of 1:1-Block address scientific-contact
    start of 1:1-Block address contact scientific-contact
    end of 1:1-Block address contact scientific-contact
  • start of 1:1-Block address public-contact
    • Institut für Hausarztmedizin der Medizinischen Fakultät der Universität Bonn
    • Ms.  Nadine  Schumacher 
    • Sigmund - Freud - Straße 25
    • 53127  Bonn
    • Germany
    end of 1:1-Block address public-contact
    start of 1:1-Block address contact public-contact
    end of 1:1-Block address contact public-contact
end of 1:n-Block addresses
start of 1:n-Block material support

Sources of Monetary or Material Support

  • start of 1:1-Block address materialSupport
    • Institut für Hausarztmedizin der Universität Bonn
    • Mr.  Prof. Dr.  Klaus  Weckbecker 
    • Sigmund-Freud-Str. 25
    • 53127  Bonn
    • Germany
    end of 1:1-Block address materialSupport
    start of 1:1-Block address contact materialSupport
    end of 1:1-Block address contact materialSupport
end of 1:n-Block material support
start of 1:1-Block state

Status

  •   Recruiting planned
  •   [---]*
end of 1:1-Block state
start of 1:n-Block publications

Trial Publications, Results and other Documents

  • [---]*
end of 1:n-Block publications
* This entry means the parameter is not applicable or has not been set.